MDCG guidance
MDCG 2024-1-5: Urogynaecological Surgical Mesh Implants used for Pelvic Organ Prolapse repair and Stress Urinary Incontinence
MDCG guidance · Post-Market Surveillance and Vigilance (PMSV) · June 2024
Key facts
| Reference | MDCG 2024-1-5 |
|---|---|
| Title | Urogynaecological Surgical Mesh Implants used for Pelvic Organ Prolapse repair and Stress Urinary Incontinence |
| Topic | Post-Market Surveillance and Vigilance (PMSV) |
| Published | June 2024 |
| Document | health.ec.europa.eu |
At a glance
- Yes Full text searchable in Orca1
- MDCG 2024-1-5 (June 2024) Revisions on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About MDCG guidance documents
The Medical Device Coordination Group (MDCG), made up of EU member-state experts, endorses guidance on applying the Medical Devices Regulation (EU) 2017/745 and the In Vitro Diagnostic Regulation (EU) 2017/746. Each page here covers one document and all of its revisions.